Document Detail


Risk factors for persistent atrial fibrillation following successful hyperthyroidism treatment with radioiodine therapy.
MedLine Citation:
PMID:  22185984     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objective To investigate the predicting factors for persistent atrial fibrillation (AF) following radioiodine therapy for hyperthyroidism. Methods Standard 12-lead ECG and 24-h Holter monitoring were performed in 94 patients (38 males, mean age 46.1±8.2 years) with persistent AF following radioiodine therapy for hyperthyroidism. Left ventricular (LV) function was assessed with two-dimensional echocardiography. Results Euthyroidism or hypothyroidism was achieved in 81% and 19% of the patients, respectively, after radioiodine therapy. At the end of follow-up (1.6±1.3 years), LV ejection fraction in the 52 patients with LV dysfunction was increased from 39.3±3.3% to 59.0±5.5% (p<0.01). In the 38 patients with pre-treatment paroxysmal AF, no AF was documented during the follow-up. In the 45 patients with pre-treatment persistent AF, AF was found in 27 (60%) during the follow-up. Multivariate logistic regression analysis showed that more than 55 years old in age (RR 2.76, 95% CI: 1.16-8.79, p<0.01), duration of hyperthyroidism (RR 3.08, 95% CI: 1.22-11.41, p<0.01) and duration of pre-treatment atrial fibrillation (RR 2.96, 95% CI: 1.31-7.68, p<0.01) were independent predictors for persistent AF following radioiodine therapy. Conclusion Older age, duration of hyperthyroidism and pre-treatment duration of AF are risk factors for persistent AF following radioiodine therapy.
Authors:
Zhen-Hu Zhou; Long-Le Ma; Le-Xin Wang
Related Documents :
11490804 - A 3-day anti-helicobacter pylori therapy is a good alternative for bleeding peptic ulce...
1776404 - Vitamin b status and response to replacement therapy in patients with burning mouth syn...
21615824 - Efficacy and safety of q-switched 1,064-nm neodymium-doped yttrium aluminum garnet lase...
21622644 - Comparison of thalidomide and lenalidomide as therapy for myelofibrosis.
10198474 - Cyclospora species as a cause of diarrhoea in humans.
17319414 - Child birth in squatting position.
Publication Detail:
Type:  Journal Article     Date:  2011-12-15
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  50     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2011  
Date Detail:
Created Date:  2011-12-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  2947-51     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship between Red Cell Distribution Width and Short-term Outcomes in Acute Coronary Syndrome ...
Next Document:  Determinants of Serum High Molecular Weight (HMW) Adiponectin Levels in Patients with Coronary Arter...